Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» triple negative breast cancer
triple negative breast cancer
Celldex's highly anticipated breast cancer drug fails to hit the mark in a midstage trial
Celldex's highly anticipated breast cancer drug fails to hit the mark in a midstage trial
Motley Fool
Celldex Therapeutics
triple negative breast cancer
glemba
Flag link:
Seattle Genetics chalks up first clinical trial success in solid tumors
Seattle Genetics chalks up first clinical trial success in solid tumors
Fierce Biotech
Seattle Genetics
clinical trials
solid tumors
SGN-LIV1A
triple negative breast cancer
Flag link:
Immunomedics Kicked Out of Prestigious ASCO Cancer Conference
Immunomedics Kicked Out of Prestigious ASCO Cancer Conference
TheStreet.com
Immunomedics
triple negative breast cancer
ASCO 2016
IMMU-132
Flag link:
Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'
Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'
Fierce Biotech
atezolizumab
Roche
PD-L1
triple negative breast cancer
Flag link:
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Yahoo
Amgen
Roche
triple negative breast cancer
Talimogene Laherparepvec
atezolizumab
colorectal cancer
Flag link:
Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer
Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer
Seeking Alpha
Medivation
Xtandi
triple negative breast cancer
breast cancer
Flag link: